IDEXX Laboratories, Inc. (IDXX)

NASDAQ: IDXX · IEX Real-Time Price · USD
576.29
+4.98 (0.87%)
At close: Feb 23, 2024, 4:00 PM
575.56
-0.73 (-0.13%)
After-hours: Feb 23, 2024, 6:45 PM EST
0.87%
Market Cap 47.86B
Revenue (ttm) 3.66B
Net Income (ttm) 845.04M
Shares Out 83.05M
EPS (ttm) 10.06
PE Ratio 57.29
Forward PE 50.65
Dividend n/a
Ex-Dividend Date n/a
Volume 256,622
Open 568.76
Previous Close 571.31
Day's Range 568.76 - 577.90
52-Week Range 372.50 - 579.68
Beta 1.25
Analysts Buy
Price Target 588.57 (+2.13%)
Earnings Date Feb 5, 2024

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imagin... [Read more]

Sector Healthcare
IPO Date Jun 21, 1991
Employees 11,000
Stock Exchange NASDAQ
Ticker Symbol IDXX
Full Company Profile

Financial Performance

In 2023, IDXX's revenue was $3.66 billion, an increase of 8.72% compared to the previous year's $3.37 billion. Earnings were $845.04 million, an increase of 24.44%.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $588.57, which is an increase of 2.13% from the latest price.

Price Target
$588.57
(2.13% upside)
Analyst Consensus: Buy
Stock Forecasts

News

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 29, 10:50 am ...

5 days ago - Business Wire

IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect

Initial Vello Users Show an Average 19% Reduction in No-Show Rate, Enabling More Clinical Visits WESTBROOK, Maine , Feb. 15, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global lead...

10 days ago - PRNewsWire

IDEXX Laboratories sees 2024 revenue above estimates

IDEXX Laboratories on Monday forecast annual revenue slightly ahead of Wall Street estimates after reporting better-than-expected quarterly sales, benefiting from higher demand for its companion anima...

20 days ago - Reuters

IDEXX Announces Fourth Quarter and Full Year Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. Fourth Quarter and Full ...

20 days ago - Business Wire

IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial r...

4 weeks ago - Business Wire

IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years

Fecal Dx antigen testing will soon detect the most common intestinal parasites earlier, uncovering more infections WESTBROOK, Maine , Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: ID...

6 weeks ago - PRNewsWire

IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows

AI-powered, load-and-go platform has potential to radically shift how veterinarians process, diagnose, and act on cytology and blood morphology cases The global launch of the IDEXX inVue Dx analyzer w...

6 weeks ago - PRNewsWire

IDEXX Laboratories Schedules Two Institutional Investor Events

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events: Thursday, Janu...

2 months ago - Business Wire

IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases

The rapid diagnostic test provides a comprehensive solution for detecting canine leishmaniosis that impacts one in 10 dogs in endemic regions WESTBROOK, Maine , Nov. 8, 2023 /PRNewswire/ -- IDEXX Labo...

3 months ago - PRNewsWire

IDEXX cuts annual sales forecast as pet owners remain cautious on vet visits

Animal health diagnostic services provider IDEXX Laboratories cut its annual sales forecast, after missing third-quarter revenue estimates on Wednesday, hurt by a slower-than-expected rise in pet owne...

4 months ago - Reuters

IDEXX Laboratories Announces Third Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company repor...

4 months ago - Business Wire

Among the S&P 500, these 20 companies have made the best use of investors' money

There is no easy way to select individual stocks. Measures of financial quality can highlight companies that are worth a closer look, but a decision to commit money must also take into consideration b...

4 months ago - Market Watch

IDEXX Laboratories to Release 2023 Third Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 third quarter results for Wednesday, Nov...

5 months ago - Business Wire

Which Is A Better Pick – Kimberly-Clark Stock Or IDEXX Laboratories?

Given its better prospects, we believe that IDEXX Laboratories stock (NASDAQ: IDXX) is a better pick over Kimberly-Clark stock (NYSE: KMB).

Other symbols: KMB
5 months ago - Forbes

IDEXX Labs lifts annual forecasts as pet owners return to vet clinics

IDEXX Laboratories raised its full-year profit and sales forecasts on Tuesday, betting on higher demand for its diagnostic tests and lab services as more pet owners visit veterinary clinics.

7 months ago - Reuters

IDEXX Laboratories Announces Second Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. Second Quarter Results The Company rep...

7 months ago - Business Wire

IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates

The 2022 report, "Purpose-Driven Progress," introduces a new framework that aligns IDEXX's ESG goals and initiatives with its long-term strategy and Purpose WESTBROOK, Maine , July 25, 2023 /PRNewswir...

7 months ago - PRNewsWire

IDEXX Laboratories Elects Irene Chang Britt to Board of Directors

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Irene Chang Britt, a former executive at Campb...

8 months ago - Business Wire

IDEXX Laboratories to Release 2023 Second Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, Augu...

8 months ago - Business Wire

IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio

The IDEXX Cystatin B Test can help veterinarians detect kidney injury before changes in kidney function, promoting better patient outcomes WESTBROOK, Maine , June 15, 2023 /PRNewswire/ -- IDEXX Labora...

9 months ago - PRNewsWire

IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, 20...

10 months ago - Business Wire

IDEXX Laboratories Announces First Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. First Quarter Results The Company repor...

10 months ago - Business Wire

IDEXX Laboratories to Release 2023 First Quarter Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 first quarter results for Tuesday, May 2...

11 months ago - Business Wire

Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity

Major gains possible by optimizing workflow, applying technology smartly, and improving talent management WESTBROOK, Maine , Feb. 20, 2023 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a gl...

1 year ago - PRNewsWire

IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results

Achieves fourth quarter revenue growth of 3% reported and 7% organic, driven by CAG Diagnostics recurring revenue growth of 4% reported and 8% organic  Solid growth supported by continued benefits fro...

1 year ago - PRNewsWire